American Health Research

American Health Research

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

American Health Research is a private, service-oriented clinical research organization (CRO) site that partners with pharmaceutical companies to conduct Phase I-IV clinical trials. It has built a dedicated facility with on-site diagnostic and laboratory capabilities, focusing on therapeutic areas like COPD, asthma, and Type 2 Diabetes. The company is led by its founder, Dr. Selwyn Spangenthal, and emphasizes regulatory compliance, certified staff, and patient-centric operations to generate reliable data for its sponsors. Its business model is based on service fees from clinical trial management, placing it in the 'Revenue Generating' stage.

COPDAsthmaType 2 Diabetes

Technology Platform

Integrated clinical research site with on-site laboratories (including sterile prep lab), secure drug storage, certified staff, and compliance systems (HIPAA, GCP, central IRB).

Opportunities

Growth in outsourced clinical trials and focus on chronic, high-prevalence diseases like COPD and Diabetes provide a steady demand for specialized research sites.
Geographic expansion into South Carolina via the Rock Hill site offers access to a new patient population and market.

Risk Factors

Revenue is dependent on winning competitive contracts from pharmaceutical sponsors, and any failure in patient recruitment or regulatory compliance could damage reputation and financial stability.
As a small private company, it faces concentration risk and limited resilience to operational disruptions.

Competitive Landscape

Competes with other independent clinical research sites, site networks, and academic medical centers in the Carolinas region. Differentiation is based on physician leadership, patient-centric facilities, operational certifications, and a track record in specific therapeutic areas like COPD.